Plasminogen Activator Inhibitor-1 in poorly controlled vs well controlled Type-2 Diabetes Mellitus patients: A case-control study in a district hospital in Ghana

BACKGROUND: Hypofibrinolysis resulting from the up-regulation of plasminogen activator inhibitor-1 (PAI-1) usually occurs in patients with type 2 diabetes mellitus (T2DM), rendering them hypercoagulable. This study assessed the plasma antigen and activity levels of the PAI-1 enzyme in T2DM patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Nkansah, Charles, Addai-Mensah, Otchere, Mensah, Kofi, Owusu, Michael, Ephraim, Richard K. D., Adu, Patrick, Osei-Boakye, Felix, Appiah, Samuel K., Serwaa, Dorcas, Derigubah, Charles A., Debrah, Alexander Yaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049243/
https://www.ncbi.nlm.nih.gov/pubmed/33857223
http://dx.doi.org/10.1371/journal.pone.0250090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049243/
https://www.ncbi.nlm.nih.gov/pubmed/33857223
http://dx.doi.org/10.1371/journal.pone.0250090

Ejemplares similares